SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615219-23-000038
Filing Date
2023-05-11
Accepted
2023-05-11 08:29:59
Documents
44
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q flks-20230331.htm   iXBRL 10-Q 533025
7 EX-31.1 slrx20230331ex-311.htm EX-31.1 8960
8 EX-33.2 slrx20230331ex-312.htm EX-33.2 8758
9 EX-32.1 slrx20230331ex-321.htm EX-32.1 6471
  Complete submission text file 0001615219-23-000038.txt   2895232

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flks-20230331.xsd EX-101.SCH 19273
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT flks-20230331_cal.xml EX-101.CAL 25908
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT flks-20230331_def.xml EX-101.DEF 90517
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flks-20230331_lab.xml EX-101.LAB 308282
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flks-20230331_pre.xml EX-101.PRE 199154
38 EXTRACTED XBRL INSTANCE DOCUMENT flks-20230331_htm.xml XML 336644
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36812 | Film No.: 23909001
SIC: 2834 Pharmaceutical Preparations